| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,035 |
1,462 |
$77K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
738 |
604 |
$37K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
374 |
345 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
325 |
302 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
649 |
530 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
152 |
120 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
43 |
40 |
$822.52 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
26 |
25 |
$815.24 |
| 87807 |
|
33 |
29 |
$260.46 |
| 36415 |
Collection of venous blood by venipuncture |
148 |
111 |
$155.92 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
13 |
13 |
$113.40 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14 |
14 |
$91.89 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
13 |
$13.24 |